Home > Healthcare > Medical Devices > Therapeutic Devices > Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy Market Size

  • Report ID: GMI2998
  • Published Date: Jul 2023
  • Report Format: PDF

Continuous Renal Replacement Therapy Market Size

Continuous Renal Replacement Therapy Market size was worth more than USD 1 billion in 2022 and is estimated to witness robust growth at 6.9% CAGR from 2023 to 2032 attributed to the rising incidences of chronic renal diseases. As per recent data from 2022, chronic kidney diseases (CKD) is projected to impact 9.1% to 13.4% of the global population.

 

The growing episodes of kidney disorders can be attributed to unhealthy lifestyles as well as the increasing prevalence of diabetes, hypertension, and other comorbidities. According to the CDC, 37.3 million Americans, or 11.3% of the population suffered from diabetes in 2022. Furthermore, the presence of rapidly expanding geriatric population base worldwide vulnerable to renal illnesses has surged the demand for CRRT treatments. Moreover, the rising demand for advanced CRRT equipment and procedures in clinical settings to offer higher effectiveness, safety, and convenience of use will add to the market expansion.  

 

The operational challenges associated with CRRT treatment methods may pose as a restraint for the market growth. To operate and manage the equipment efficiently, CRRT requires specialized training and technical knowledge. Increasing errors in machine setup, parameter modifications, or patient management leading to complications along with the shortage of qualified workers may also slow down the market growth.

 

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Continuous renal replacement therapy industry size was over USD 1 billion in 2022 and is projected to expand at 6.9% CAGR from 2023 to 2032, driven by the increasing prevalence of chronic renal diseases globally.

The consumables segment is estimated to reach USD 1.3 billion by 2032 owing to the widespread adoption of high-performance hemofilters and dialyzers.

North America continuous renal replacement therapy industry size exceeded USD 371 million in 2022 and will record substantial growth through 2032 attributed to the high demand for CRRT from the expanding senior population prone to renal failure.

Some of the major companies engaged in the continuous renal replacement therapy industry are Medtronic, B.Braun Melsungen, Asahi Kasei Corporation, Baxter International Inc., Medica, Medites, Medical Components, Nikkiso, Nxtstage, Toray, and Tricol Biomedical.

Continuous Renal Replacement Therapy Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 361
  • Countries covered: 30
  • Pages: 160
 Download Free Sample